Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | FABP2 | P12104 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL22437492 | 0.98 | HPGD (0.46) | HPGDKMT2AMEN1PPARACYP1A2 | |
| SCHEMBL31532258 | 0.98 | MEN1 (0.46) | HPGDKMT2AMEN1PPARACYP1A2 | |
| SCHEMBL27406073 | 0.98 | HPGD (0.46) | HPGDKMT2AMEN1PPARACYP1A2 | |
| Diethanolamine SCHEMBL25288907 | 0.85 | KDM4E (0.46) | KMT2ACYP1A2CYP2D6CYP2C19MAOA | |
| SCHEMBL10727330 | 0.82 | CYP1A2 (0.44) | KMT2AMEN1PPARACYP1A2MAPT | |
| SCHEMBL25288908 | 0.82 | MAOA (0.36) | HPGDKMT2AMEN1PPARACYP1A2 | |
| SCHEMBL10438873 | 0.80 | LMNA (0.61) | HPGDCYP3A4MAPTMAOBSMN1; SMN2 | |
| SCHEMBL6200881 | 0.80 | MEN1 (0.44) | KMT2AMEN1CYP3A4MAPTELANE | |
| SCHEMBL8586307 | 0.80 | CES2 (0.52) | KMT2AMEN1MAPTSMN1; SMN2CES2 | |
| SCHEMBL28617865 | 0.79 | RAB9A (0.46) | HPGDKMT2AMEN1CYP2D6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1558220-B1 | ORAL COMPOSITIONS FOR TREATMENT OF DIABETES | WOCKHARDT LTD (IN) | 2010-02-10 | — | — | EP | claimed |
| CN-1684682-A | Small organic molecules that increase the activity of gelatinase A in ocular cells | BAUSCH & LOMB (US) | 2005-10-19 | — | — | CN | claimed |
| CN-1503626-A | Herbicidal composition containing benzoylcyclohexanediones and safeners | �Ϻ���ͨ��ѧ | 2004-06-09 | — | — | CN | claimed |
| US-20260076972-A1 | ANTIDIABETIC MEDICATIONS | BOEHRINGER INGELHEIM INT (DE) | 2026-03-19 | — | — | US | disclosed |
| EP-4701626-A1 | AMORPHOUS OBICETRAPIB AND SGLT2 INHIBITOR COMBINATION | NewAmsterdam Pharma B.V. (NL) | 2026-03-04 | — | — | EP | disclosed |
| EP-4642434-A2 | LIPID COMPOSITIONS ON THE BASIS OF IONIZABLE LIPIDS, USE FOR DELIVERY TO IMMUNE CELLS | Life Technologies Corporation (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12458700-B2 | Amine-containing transfection reagents and methods for making and using same | Life Technologies Corporation (US) | 2025-11-04 | — | — | US | disclosed |
| WO-2025151874-A1 | INDOLE ALKALOID ANTIPLASMODIAL AGENTS AND PREPARATION THEREOF | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20250170128-A1 | Obicetrapib and SGLT2 Inhibitor Combination | NEWAMSTERDAM PHARMA B.V. (NL) | 2025-05-29 | — | — | US | disclosed |
| WO-2025072886-A9 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2025-05-15 | — | — | WO | disclosed |
| EP-3654955-B1 | PHARMACEUTICAL COMPOSITIONS | LILLY CO ELI (US) | 2025-05-07 | — | — | EP | disclosed |
| EP-0807118-A2 | NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME | GILEAD SCIENCES, INC. (US) | 1997-11-19 | — | — | EP | disclosed |
| WO-1996023801-A2 | NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME | GILEAD SCIENCES, INC. (US) | 1996-08-08 | — | — | WO | disclosed |
| EP-0661907-A2 | Liquid-type transformerless thermal evaporating device | EARTH CHEMICAL CO., LTD. (JP) | 1995-07-05 | — | — | EP | disclosed |
| EP-0555938-A1 | Use of phenoxyacetate derivatives for the restoration of neural function | Albert ROLLAND S.A. (FR) | 1993-08-18 | — | — | EP | disclosed |
| EP-0487623-A1 | DERIVATIVES OF 5-AMINO-1,2,3,4 TETRAHYDRO-ACRIDINE AND APPLICATIONS AS DRUGS | SYNTHESES ET RECHERCHES (FR) | 1992-06-03 | — | — | EP | disclosed |
| WO-1991002725-A1 | DERIVATIVES OF 5-AMINO-1,2,3,4 TETRAHYDRO-ACRIDINE AND APPLICATIONS AS DRUGS | SYNTHESES ET RECHERCHES (FR) | 1991-06-07 | — | — | WO | disclosed |
| EP-0117675-B1 | BENZOFURAN AND BENZOTHIOPHENE-CARBOXYLIC-ACID DERIVATIVES | BEECHAM GROUP PLC (GB) | 1986-07-23 | — | — | EP | disclosed |
| US-4548948-A | Anti-inflammatory and analgesic benzothiophene and benzafuran derivatives, compositions, and method of use therefor | BEECHAM GROUP P.L.C. (GB) | 1985-10-22 | — | — | US | disclosed |
| EP-0117675-A1 | Benzofuran and benzothiophene-carboxylic-acid derivatives | BEECHAM GROUP PLC (GB) | 1984-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12458700-B2 | Amine-containing transfection reagents and methods for making and using same | SNRPA, NUDT21, SOAT2 | HPGD 2842/4885KMT2A 908/4885MEN1 746/4885 |
| US-20250170128-A1 | Obicetrapib and SGLT2 Inhibitor Combination | SLC5A2, SLC5A1, SLC2A2 | HPGD 3914/4885KMT2A 220/4885MEN1 4550/4885 |
| US-20260076972-A1 | ANTIDIABETIC MEDICATIONS | IAPP, DPP4, PYGL | HPGD 4343/4885KMT2A 3992/4885MEN1 2843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.